Identification and management of pragmatic clinical trial collateral findings: A current understanding and directions for future research-Reference-Cited by-同舟云学术

Identification and management of pragmatic clinical trial collateral findings: A current understanding and directions for future research

Published:2021-12 Issue:4 Volume:9 Page:100586
ISSN:2213-0764
Container-title:Healthcare
language:en
Short-container-title:Healthcare

Author:

Morain Stephanie R.^ORCID,Mathews Debra J.H.^ORCID,Geller Gail,Bollinger Juli^ORCID,Weinfurt Kevin,Jarvik Jeffrey G.^ORCID,May Elizabeth,Sugarman Jeremy^ORCID

Funder

National Center for Complementary and Integrative Health

National Institutes of Health

National Institutes of Health Office of the Director

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Publisher

Elsevier BV

Subject

Health Policy

Reference27 articles.

1. Ethics and regulatory complexities for pragmatic clinical trials;Sugarman;J Am Med Assoc,2014

2. Exploring the ethical and regulatory issues in pragmatic clinical trials;Califf;Clin. Trials J. Soc. Clin Trials,2015

3. Ethics and collateral findings in pragmatic clinical trials;Morain;Am. J. Bioeth AJOB,2020

4. Bystander ethics and good samaritanism: a paradox for learning health organizations;Sabin;Hastings Cent Rep,2019

5. Positive predictive values of fecal immunochemical tests used in the STOP CRC pragmatic trial;Nielson;Cancer Med,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurring and Emerging Ethical Issues in Pragmatic Clinical Trials;Circulation: Cardiovascular Quality and Outcomes;2024-07

2. Stakeholder perspectives on data sharing from pragmatic clinical trials: Unanticipated challenges for meeting emerging requirements;Learning Health Systems;2023-05

3. Patient responses to passive enrollment into a large, pragmatic clinical trial: A qualitative content analysis;Contemporary Clinical Trials;2022-10